Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Bolsa de Madrid  >  FAES Farma SA    FAE   ES0134950F36

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bolsa De Madrid
12/01/2016 12/02/2016 12/05/2016 12/06/2016 12/07/2016 Date
3.295(c) 3.26(c) 3.33(c) 3.345(c) 3.29(c) Last
314 823 155 208 198 616 90 319 236 655 Volume
-2.23% -1.06% +2.15% +0.45% -1.64% Change
More quotes
Financials (€)
Sales 2016 225 M
EBIT 2016 44,6 M
Net income 2016 36,0 M
Finance 2016 46,8 M
Yield 2016 1,84%
Sales 2017 245 M
EBIT 2017 59,5 M
Net income 2017 33,0 M
Finance 2017 72,6 M
Yield 2017 2,60%
P/E ratio 2016 23,17
P/E ratio 2017 17,65
EV / Sales2016 3,51x
EV / Sales2017 3,13x
Capitalization 839 M
More Financials
Company
Faes Farma SA engages in the manufacture, marketing, and research of pharmaceutical products and raw materials for pharmaceutical use. Its products are for allergies, antihypertensive, dermatological, diabetes, digestive, otorhinolaryngology, osteoarticular, respiratory, women's health, central... 
Sector
Pharmaceuticals
Calendar
03/06Earnings Release
More about the company
Surperformance© ratings of FAES Farma SA
Trading Rating : Investor Rating :
More Ratings
Latest news on FAES FARMA SA
06/28 FAES FARMA SA : ex-dividend day for final dividend
2015 FAES FARMA SA : ex-dividend day for final dividend
2015 FAES FARMA : Statement 05/18/2015 (39 k.). Faes Farma has licensed a pharmaceuti..
2015 FAES FARMA : Comunicado 05/01/2015 (59 k.). Dividendo flexible. Datos de cierre ..
2015 FAES FARMA : Statement 02/27/2015 (81 k.). Faes Farma increases its net probit b..
2014 FAES FARMA : Statement 05/14/2014 (112 k.). Bilastine in Canada: signing of a li..
2014 FAES FARMA : Statement 05/14/2014 (112 k.). Bilastine in Canada: signing of a li..
2013 FAES FARMA SA : Statement 07/24/2013 (24 k.). January-June results.
2012 FAES FARMA SA : Statement 13/12/2012 (20 k). Faes Farma licences bilastine for S..
2012 FAES FARMA SA : Statement 02/07/2012 (19 k). FAES FARMA S.A. informs of the appr..
More news
Sector news : Pharmaceuticals - NEC
12/07 MYLAN : EpiPen maker Mylan to restructure, cut workforce
12/07DJABBOTT LABORATORIES : Seeks to Terminate Alere Deal -- Update
12/07DJPFIZER : Fined $107 Million for Overcharging U.K. for Epilepsy Drug
12/07DJABBOTT LABORATORIES : Seeks to Terminate Alere Deal
12/07DJMARKET SNAPSHOT : Dow, S&P 500 Set Intraday Records, But Health-care Slumps On T..
More sector news : Pharmaceuticals - NEC
Advertisement
Chart FAES FARMA SA
Duration : Period :
FAES Farma SA Technical Analysis Chart | FAE | ES0134950F36 | 4-Traders
Full-screen chart
Technical analysis trends FAES FARMA SA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Average target price 3,25 €
Spread / Average Target -1,1%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Gonzalo López Casanueva Co-Managing Director
Francisco Quintanilla Guerra Co-Managing Director
Mariano Ucar Angulo Chairman
Valentín Ruiz Unamunzaga Deputy MD & Director-Corporate Finance
Isidro Hermo Blanco Manager-Pharmaceutical Technology
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
FAES FARMA SA19.20%903
JOHNSON & JOHNSON8.16%302 251
ROCHE HOLDING LTD.-19.14%189 614
PFIZER INC.-2.23%189 272
NOVARTIS AG-20.05%178 826
MERCK & CO., INC.13.71%165 594
More Results